Chapter 11: Cancer: Cell Division Out of Control - PowerPoint PPT Presentation

1 / 31
About This Presentation
Title:

Chapter 11: Cancer: Cell Division Out of Control

Description:

Cancer is a group of diseases caused by rapid and inappropriate cell division. ... with a benign growth called a polyp that can eventually transform into a ... – PowerPoint PPT presentation

Number of Views:37
Avg rating:3.0/5.0
Slides: 32
Provided by: jason67
Category:

less

Transcript and Presenter's Notes

Title: Chapter 11: Cancer: Cell Division Out of Control


1
Chapter 11 Cancer Cell Division Out of Control
2
Key Concepts
  • Cancer is a group of diseases caused by rapid and
    inappropriate cell division. The resulting cell
    proliferation can form a tumor from which
    cancerous cells may spread, invading other
    tissues in the body.
  • All multicellular organisms have ways of
    regulating the proliferation of different types
    of cells. When a cell loses its ability to
    respond to these regulatory signals, it divides
    uncontrollably, leading to cancer.
  • Genes that promote cell division in response to
    normal growth signals are called proto-oncogenes.
    Overactive mutant versions of these genes can
    lead to excessive cell division and cancer.
  • Genes that inhibit cell division under normal
    conditions are called tumor suppressor genes. The
    complete loss of tumor suppressor activity can
    also lead to excessive cell division and cancer.
  • When and how often a cell divides depends on the
    balance between the promoting effects of
    proto-oncogenes and the inhibiting effects of
    tumor suppressor genes.
  • Most cancers are caused by a combination of
    environmental factors. A minority of cancers can
    be traced to inherited genetic defects.

3
(No Transcript)
4
Cancer Terminology
  • carcinoma  (kar-sin-O-ma) Cancer that begins in
    the skin or in tissues that line or cover
    internal organs.
  • metastasize  (meh-TAS-ta-size) To spread from one
    part of the body to another. When cancer cells
    metastasize and form secondary tumors, the cells
    in the metastatic tumor are like those in the
    original (primary) tumor.
  • neoplasia  (NEE-o-PLAY-zha) Abnormal and
    uncontrolled cell growth.
  • neoplasm   A new growth of benign or malignant
    tissue.
  • neuroblastoma   Cancer that arises in immature
    nerve cells and affects mostly infants and
    children.
  • sarcoma   A cancer of the bone, cartilage, fat,
    muscle, blood vessels, or other connective or
    supportive tissue.

5
This would be a carcinoma
6
Positive Growth Regulators Promoting Cell
Division
  • Peyton Rous discovered that a virus could cause
    cancer in chickens (Figure 11.2).
  • Some viruses can cause cancer
  • Viruses are tiny assemblages of either RNA or DNA
    surrounded by protein.
  • By studying mutant forms of the Rous sarcoma
    virus that did not cause infected cells to divide
    uncontrollably, scientists determined that a
    single viral protein kinase was responsible for
    tumor formation.
  • The viral protein kinase overstimulates host cell
    signaling cascades.

7
(No Transcript)
8
Oncogenes play an important role in cancer
development
  • The protein kinase that causes Rous sarcoma
    formation is named Src.
  • Src is an oncogene (a cancer-causing gene found
    in viruses).
  • Src is a mutant form of a gene normally found in
    host cells.
  • A mutation is a change in the DNA sequence of a
    gene.
  • Mutations of genes can alter the activity of the
    proteins they encode.
  • In the case of Src, the mutation results in an
    overactive protein kinase.
  • Proto-oncogenes are normal cellular genes that
    are predecessors of viral oncogenes.

9
(No Transcript)
10
Proto-oncogenes produce many of the proteins in
signal cascades
  • Any gene that produces a protein used in the cell
    division cycle can be a proto-oncogene (Figure
    11.3).
  • Oncogenes are overactive mutant versions of
    proto-oncogenes, and they promote excessive cell
    division.
  • Figure 11.4 shows one example of how an oncogene
    causes cancer.

11
(No Transcript)
12
Negative Growth Regulators Inhibiting Cell
Division
  • Tumor suppressor genes stop cells from dividing
    by opposing the action of proto-oncogenes.
  • In order for a cell to divide, proto-oncogenes
    must be activated and tumor suppressor genes must
    be inactivated.

13
(No Transcript)
14
Tumor suppressors block specific steps of growth
factor signal cascades
  • Retinoblastoma (cancer of the retina) occurs
    because of the absence of a gene on chromosome 13
    (Rb).
  • Rb is a tumor suppressor gene.
  • When Rb is present, it inhibits cell division by
    inactivating regulatory proteins that are
    required for a cell to respond to growth factor
    signals.
  • Rb is inactivated by phosphorylation from growth
    factor signal cascades, which allows cell
    division to proceed (Figure 11.6).
  • The example of Rb shows that positive and
    negative regulatory controls are necessary for
    cell division to occur.

15
(No Transcript)
16
Both copies of a tumor suppressor gene must be
mutated to cause cancer
  • In order for an oncogene to cause cancer, only
    one copy must be mutated.
  • A tumor suppressor gene must be completely absent
    to allow cancerous cell division to occur (Figure
    11.7).

17
(No Transcript)
18
(No Transcript)
19
(No Transcript)
20
A Series of Chance Events Can Cause Cancer
  • Inherited and environmental factors are both
    involved in promoting human cancers.
  • 95 percent of cancer cases are caused by
    inherited and environmental factors or
    environmental factors alone.
  • About five percent of cancers are caused by
    inherited genetic defects alone.

21
Cancer is a multi-step process
  • Cancer is a common disease in American men and
    women (Table 11.1).
  • Several cellular safeguards have to fail before a
    cancerous tumor can form.
  • Colon cancer begins with a benign growth called a
    polyp that can eventually transform into a
    malignant tumor (Figure 11.8).
  • Loss of p53 protein in a cell removes all
    controls on cell division.

22
(No Transcript)
23
Cancer is a multi-step process
  • Cancer is a common disease in American men and
    women (Table 11.1).
  • Several cellular safeguards have to fail before a
    cancerous tumor can form.
  • Colon cancer begins with a benign growth called a
    polyp that can eventually transform into a
    malignant tumor (Figure 11.8).
  • Loss of p53 protein in a cell removes all
    controls on cell division.

24
(No Transcript)
25
Cancer is often related to lifestyle choices
  • A study of 44,000 pairs of twins revealed that
    the most important contributor to cancer risk was
    the environment (including lifestyle and
    behavior).
  • Cigarette smoking has been recognized as the
    leading cause of cancer mortality in the United
    States.
  • A carcinogen is a physical, chemical, or
    biological agent that causes cancer.
  • Tobacco smoke contains 40 known carcinogens.
  • People who quit smoking before age 50 reduce
    their risk of dying during the subsequent 15
    years by half.
  • Behavioral changes can reduce the risk of many
    types of cancer.

26
Highlight Making the Most of Losing p53
  • The tumor suppressor protein p53 prevents the
    cell from dividing at inappropriate times.
  • p53 is not active in cancer cells.
  • Adenoviruses can only replicate in cells where
    p53 is inactivated (usually by a protein for
    which the virus codes).
  • Cancer researchers have mutated an adenovirus so
    that it will not inhibit p53 by itself
    therefore, the mutant viruses can only infect
    cells in which p53 is inactive.
  • Cancerous cells frequently lack p53 activity, so
    the mutant virus can be used to selectively
    infect and kill cancer cells.
  • Adenovirus cancer therapy is still being
    researched as a potential treatment.

27
(No Transcript)
28
P53, Continued
  • THE p53 GENE like the Rb gene, is a tumor
    suppressor gene, i.e., its activity stops the
    formation of tumors. If a person inherits only
    one functional copy of the p53 gene from their
    parents, they are predisposed to cancer and
    usually develop several independent tumors in a
    variety of tissues in early adulthood. This
    condition is rare, and is known as Li-Fraumeni
    syndrome. However, mutations in p53 are found in
    most tumor types, and so contribute to the
    complex network of molecular events leading to
    tumor formation.

29
P53, Continued
  • The p53 gene has been mapped to chromosome 17. In
    the cell, p53 protein binds DNA, which in turn
    stimulates another gene to produce a protein
    called p21 that interacts with a cell
    division-stimulating protein (cdk2). When p21 is
    complexed with cdk2 the cell cannot pass through
    to the next stage of cell division. Mutant p53
    can no longer bind DNA in an effective way, and
    as a consequence the p21 protein is not made
    available to act as the 'stop signal' for cell
    division. Thus cells divide uncontrollably, and
    form tumors.

30
P53, Continued
  • Normally, damage to cellular DNA initiates
    increased expression of TP53, which leads to
    arrest of the cell cycle. This interruption
    permits DNA repair to occur before the cell
    resumes the cell cycle and normal cell
    proliferation. If the DNA repair is not
    successful, then the cell then undergoes
    apoptosis, or cell death. When TP53 mutates,
    DNA-damaged cells are not arrested in G1 and DNA
    repair does not take place. This failure to
    arrest DNA-damaged cells will be repeated in
    subsequent cell cycles, permitting other
    mutations to accumulate and culminating in
    neoplastic transformation...tumor formation and
    cancer.

31
First Adenoviral-p53 Gene Therapy Trial Shows
Success In Lung Cancer
  • DENVER, May 20, 1997 -- Researchers from The
    University of Texas M.D. Anderson Cancer Center
    reported that the first Adenoviral-p53 (Ad-p53)
    gene therapy study utilizing the tumor suppressor
    p53 gene was well-tolerated and showed evidence
    of clinical activity in patients with
    non-small-cell lung cancer, according to data
    presented here today at the 33rd Annual Meeting
    of the American Society of Clinical Oncology
    (ASCO). Additionally, the treatment appeared to
    be more active when used in combination with a
    common chemotherapeutic agent, cisplatin.
Write a Comment
User Comments (0)
About PowerShow.com